Background Although an association of occurrence of menopause and subsequent oestrogen deficiency with increased cardiovascular disease has been postulated, studies on this association have not shown convincing results. We investigated whether age at menopause is
Introduction
Premenopausal women seem to be protected against cardiovascular morbidity and mortality in comparison with men of similar age or postmenopausal women.'-' Loss of ovarian function and subsequent deficiency of endogenous oestrogens is suggested to promote cardiovascular disease and death after menopause . 4, 1 If endogenous oestrogens protect against cardiovascular disease, an early menopause might incur a higher risk, because of lower exposure to oestrogens. Evidence for this hypothesis has been inconclusive. 6 Several investigations had small sampless,7-9 and angina pectoris was used as the endpoint in some. 5, 10, 11 The two prospective studies that have been done, the Framingham Heart Study2 and the Nurses' Health Study,3 were better designed to address the question of whether the menopause itself is a risk factor for cardiovascular disease than to show whether an early menopause poses a particular risk. The main problem of studies done so far is the short postmenopausal follow-up period, which has probably been too short for cardiovascular diseases to occur in sufficient frequency for statistical analysis.
To explore the relation between the age at menopause and subsequent cardiovascular mortality, we studied a cohort of postmenopausal women aged 50-65 years at enrolment in an experimental breast cancer screening project in 1974-77; the women were followed up for a median of 16 years (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 
years).

Patients and methods
Patients
Between December, 1974, and September, 1977, 14 697 The effect of smoking on cardiovascular mortality seems to be so strong as to over-ride the effect of an early menopause.
The evidence that reduced exposure to endogenous oestrogens leads to increased cardiovascular morbidity has mainly come from studies of postmenopausal exogenous oestrogen replacement,6 for which a relative risk of 0-56 (95% CI 0-50-0-61) has been estimated. 22 Morbidity and mortality statistics suggest that the decrease in the gap between cardiovascular morbidity and mortality in men and women cannot be attributed to the menopause.9,23-25 Women who live and work by selling sex in Pumwani, a poor
